Smofkabiven Peripheral 350 mg

SMOFKABIVEN Peripheral 350 mg is an intravenous emulsion containing glycine, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is suitable for peripheral administration.

SMOFKABIVEN Peripheral 350 mg is primarily used for nutritional support in patients who cannot consume food orally. This intravenous emulsion provides essential amino acids and calories, which are crucial for maintaining proper nutrition and overall health. It is often used in clinical settings where patients require parenteral nutrition.

When administered intravenously, SMOFKABIVEN Peripheral 350 mg provides the body with necessary nutrients that support various metabolic functions. Patients may experience improved energy levels and overall well-being as the body utilizes these nutrients. However, individual responses can vary.

SMOFKABIVEN Peripheral 350 mg should be administered under the supervision of a healthcare professional. It is important to follow proper handling and storage guidelines to ensure the emulsion remains stable and effective. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

SMOFKABIVEN Peripheral 350 mg may interact with other medications or supplements. It is advisable to inform your healthcare provider about all current medications to avoid potential interactions. Additionally, compatibility with other intravenous solutions should be checked before administration.